Unbiased AI-powered news
Abbott Laboratories has reported double-digit year-over-year growth in its Medical Devices segment for the first quarter of the year, while its nutrition segment has experienced a decline. The company continues to focus on expanding its medical device offerings.
Substrate placeholder — needs reviewAbbott Laboratories announced that its Medical Devices segment has seen double-digit year-over-year growth in the first quarter of the year. This growth reflects the company's ongoing investment in new technologies and product development. In contrast, Abbott's nutrition segment reported a decline during the same period.
The company is addressing challenges in this area as it seeks to enhance its overall performance across different business segments. Abbott Laboratories continues to prioritize its medical devices division, which has been a key driver of revenue. The company aims to leverage advancements in technology to maintain its competitive position in the healthcare market.
Claude Guillemot, 69, died Friday when the Cessna 421 he was piloting crashed near La Baule-Escoublac Airport in western France. A flight instructor on board was also killed.
The Japan TimesChinese customs data show zero shipments of certain tungsten types, dysprosium and terbium to Japan last month. A broader rare-earth category reached its lowest three-month rolling total since 2023.
New York PostA Los Angeles County report estimates the $111 billion Paramount-Warner Bros. Discovery merger could eliminate 2,500 local jobs and 6,000 positions worldwide. The combined company carries an $82 billion debt load and plans $6 billion in savings through consolidation.